Our study links obesity-dependent CXCL1/CXCR1 gradient activation in the prostate with obesity-dependent cancer progression reported previously22, 23, 24, 25, 26. This evidence concerns the gene CXCL1 and obesity due to melanocortin 4 receptor deficiency.